Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Mar 2025 for Trevi Therapeutics, Inc., €3,482. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Thomas Sciascia: trading record in brief
Thomas Sciascia appears in our data through filings on Trevi Therapeutics, Inc. shares, published by SEC (Form 4). Between 29 May 2024 and 25 March 2025, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 26 March 2025 with an option exercise (€3,482) in Trevi Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas Sciascia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,631 shares@ US$1.432.4% of flowCommon StockSEC:0000950170-25-045295:0
16,496 shares@ US$1.4314.7% of flowCommon StockSEC:0000950170-24-099481:0
100 shares@ US$1.430.1% of flowCommon StockSEC:0000950170-24-098117:0
59,354 shares@ US$2.1982.9% of flowCommon StockSEC:0000950170-24-067305:0
4 of 4 declarations
